• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小蛋白LINC01547-ORF通过调节CLDN18-FAK-AKT轴抑制结直肠癌进展。

The small protein LINC01547-ORF inhibits colorectal cancer progression by regulating the CLDN18-FAK-AKT axis.

作者信息

Zhang Shuai, Xu Siguang, Li Dandan, Wu Songxin, Han Miaomiao, Han Yifei, Wang Zixi, Qiao Dan, Yuan Hang, Du Baoshun, Chen Hongwei, Zhang Zheying

机构信息

Department of Pathology, School of Basic Medical Sciences, Xinxiang Medical University Xinxiang 453003, Henan, China.

Department of Emergency Center Emergency Critical Care, The Fourth Clinical College of Xinxiang Medical College Xinxiang 453003, Henan, China.

出版信息

Am J Cancer Res. 2024 Nov 15;14(11):5504-5520. doi: 10.62347/PNKH7683. eCollection 2024.

DOI:10.62347/PNKH7683
PMID:39659940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11626262/
Abstract

Long non-coding RNA (lncRNA)-encoded small proteins play a major role in colorectal cancer. To identify more functional encoded small proteins, ribosome profiling data from colorectal cancer (CRC) cells were screened for ribosome-associated lncRNAs. The search identified LINC01547 that was shown to encode a small protein of 76 amino acids, termed LINC01547-ORF. Real-time quantitative fluorescence showed that LINC01547 expression was downregulated in colorectal cancer tissues. However, cell functional assays revealed that LINC01547 inhibited the proliferation and migration of colorectal cancer cell lines. Meanwhile, western blot and immunofluorescence assays confirmed that LINC01547 encoded LINC01547-ORF. Cellular functional assays indicated that compared with LINC01547 itself, LINC01547-ORF inhibited the proliferation and migration of colorectal cancer cell lines. Gene set enrichment analysis identified enrichment in the focal adhesion pathway and association with CLDN18 protein, whereas protein molecular docking models revealed interacting domains and amino acid residue sites. Of note, co-immunoprecipitation and immunofluorescence experiments showed that LINC01547-ORF could bind to the CLDN18 protein and that this interaction reduced CLDN18 ubiquitination, thereby promoting protein expression. Finally, western blot and immunofluorescence assays confirmed that LINC01547-ORF could target CLDN18 to inhibit the FAK/PI3K/AKT signaling pathway, suppressing colorectal cancer cell development. These findings suggest that the LINC01547-ORF-encoded small protein inhibits proliferation and migration in colorectal cancer, thereby offering a promising direction for treating this disease.

摘要

长链非编码RNA(lncRNA)编码的小蛋白在结直肠癌中起主要作用。为了鉴定更多具有功能的编码小蛋白,对来自结直肠癌细胞的核糖体分析数据进行筛选,以寻找与核糖体相关的lncRNA。该筛选鉴定出LINC01547,它被证明可编码一种由76个氨基酸组成的小蛋白,称为LINC01547-ORF。实时定量荧光显示,LINC01547在结直肠癌组织中的表达下调。然而,细胞功能实验表明,LINC01547抑制了结直肠癌细胞系的增殖和迁移。同时,蛋白质印迹和免疫荧光实验证实LINC01547编码LINC01547-ORF。细胞功能实验表明,与LINC01547本身相比,LINC01547-ORF抑制了结直肠癌细胞系的增殖和迁移。基因集富集分析确定了粘着斑通路中的富集以及与CLDN18蛋白的关联,而蛋白质分子对接模型揭示了相互作用结构域和氨基酸残基位点。值得注意的是,免疫共沉淀和免疫荧光实验表明,LINC01547-ORF可与CLDN18蛋白结合,这种相互作用减少了CLDN18的泛素化,从而促进了蛋白表达。最后,蛋白质印迹和免疫荧光实验证实,LINC01547-ORF可靶向CLDN18以抑制FAK/PI3K/AKT信号通路,从而抑制结直肠癌细胞的发展。这些发现表明,LINC01547-ORF编码的小蛋白可抑制结直肠癌的增殖和迁移,从而为治疗这种疾病提供了一个有前景的方向。

相似文献

1
The small protein LINC01547-ORF inhibits colorectal cancer progression by regulating the CLDN18-FAK-AKT axis.小蛋白LINC01547-ORF通过调节CLDN18-FAK-AKT轴抑制结直肠癌进展。
Am J Cancer Res. 2024 Nov 15;14(11):5504-5520. doi: 10.62347/PNKH7683. eCollection 2024.
2
Silencing LINC01547 induces hepatocellular carcinoma cell apoptosis and metastasis inhibition via the ADAR1/FAK and miR-146b-5p/RAC1 axes.沉默LINC01547通过ADAR1/FAK和miR-146b-5p/RAC1轴诱导肝癌细胞凋亡并抑制转移。
Apoptosis. 2025 Apr;30(3-4):936-954. doi: 10.1007/s10495-024-02070-0. Epub 2025 Feb 4.
3
Long intergenic non-protein-coding RNA 1547 acts as a competing endogenous RNA and exerts cancer-promoting activity in non-small cell lung cancer by targeting the microRNA-195-5p/ homeobox C8 axis.长链基因间非编码RNA 1547作为一种竞争性内源性RNA,通过靶向微小RNA-195-5p/同源盒C8轴在非小细胞肺癌中发挥促癌作用。
Heliyon. 2023 Jul 26;9(8):e18015. doi: 10.1016/j.heliyon.2023.e18015. eCollection 2023 Aug.
4
Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway.长链非编码 RNA ABHD11-AS1 通过靶向整合素亚基α5/黏着斑激酶/磷酸肌醇 3 激酶/蛋白激酶 B 信号通路促进结直肠癌的进展和侵袭。
Aging (Albany NY). 2021 Aug 10;13(16):20179-20191. doi: 10.18632/aging.203342.
5
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling.硫酸酯酶1通过FAK/PI3K/AKT/mTOR信号通路调节ARSH,从而调控结直肠癌的恶性进展。
Cancer Cell Int. 2024 Jun 6;24(1):201. doi: 10.1186/s12935-024-03383-5.
6
The Novel LncRNA WASH5P Inhibits Colorectal Cancer Carcinogenesis Targeting AKT Signaling Pathway.新型长链非编码RNA WASH5P通过靶向AKT信号通路抑制结直肠癌发生
Front Oncol. 2022 Jul 11;12:923425. doi: 10.3389/fonc.2022.923425. eCollection 2022.
7
The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.结直肠癌中上调的 lncRNA DLX6-AS1 通过调节 PI3K/AKT/mTOR 通路促进细胞增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8321-8331. doi: 10.26355/eurrev_201910_19143.
8
LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.长链非编码 RNA AB073614 通过 PI3K/AKT 信号通路调节结直肠癌细胞的增殖和转移。
Biomed Pharmacother. 2017 Sep;93:1230-1237. doi: 10.1016/j.biopha.2017.07.024. Epub 2017 Jul 20.
9
BVES-AS1 suppresses the colorectal cancer progression via the miR-1269a/b-SVEP1-PI3K/AKT axis.BVES-AS1通过miR-1269a/b-SVEP1-PI3K/AKT轴抑制结直肠癌进展。
Adv Clin Exp Med. 2024 Nov;33(11):1217-1236. doi: 10.17219/acem/175050.
10
Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells and by blocking the activation of the FAK/AKT/β‑catenin signaling pathway.长链非编码 RNA MIR4435-2HG 和 ST8SIA1 表达的敲低通过阻断 FAK/AKT/β-连环蛋白信号通路的激活抑制前列腺癌细胞的增殖、侵袭和迁移。
Int J Mol Med. 2021 Jun;47(6). doi: 10.3892/ijmm.2021.4926. Epub 2021 Apr 13.

本文引用的文献

1
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling.硫酸酯酶1通过FAK/PI3K/AKT/mTOR信号通路调节ARSH,从而调控结直肠癌的恶性进展。
Cancer Cell Int. 2024 Jun 6;24(1):201. doi: 10.1186/s12935-024-03383-5.
2
ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner.ZNF460 通过 ITGA5 诱导的 FAK/PI3K/AKT 激活促进三阴性乳腺癌进展的环状 RNA RPPH1 的 ceRNA 方式。
Mol Cancer. 2024 Feb 14;23(1):33. doi: 10.1186/s12943-024-01944-w.
3
The microbial landscape of colorectal cancer.结直肠癌的微生物景观
Nat Rev Microbiol. 2024 Apr;22(4):240-254. doi: 10.1038/s41579-023-00973-4. Epub 2023 Oct 4.
4
Distinct regulatory functions and biological roles of lncRNA splice variants.长链非编码RNA剪接变体的独特调控功能和生物学作用。
Mol Ther Nucleic Acids. 2023 Mar 15;32:127-143. doi: 10.1016/j.omtn.2023.03.004. eCollection 2023 Jun 13.
5
Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling.健脾养正汤通过调节miR-448/CLDN18.2介导的YAP/TAZ信号通路抑制胃癌进展。
J Ethnopharmacol. 2023 Jul 15;311:116450. doi: 10.1016/j.jep.2023.116450. Epub 2023 Apr 5.
6
Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications.靶向CLDN18.2治疗胃肠道癌症:新药与新适应症
Front Oncol. 2023 Mar 10;13:1132319. doi: 10.3389/fonc.2023.1132319. eCollection 2023.
7
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer.泛素连接酶 TRIM21 调节癌症中突变型 p53 的积累和获得功能。
J Clin Invest. 2023 Mar 15;133(6):e164354. doi: 10.1172/JCI164354.
8
LINC00998-encoded micropeptide SMIM30 promotes the G1/S transition of cell cycle by regulating cytosolic calcium level.LINC00998 编码的微小肽 SMIM30 通过调节细胞质钙水平促进细胞周期的 G1/S 期转换。
Mol Oncol. 2023 May;17(5):901-916. doi: 10.1002/1878-0261.13358. Epub 2022 Dec 29.
9
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.微小肽 MIAC 通过与 AQP2 相互作用并抑制肾细胞癌中的 EREG/EGFR 信号传导来抑制肿瘤进展。
Mol Cancer. 2022 Sep 19;21(1):181. doi: 10.1186/s12943-022-01654-1.
10
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.Claudin18.2是一种用于肿瘤靶向免疫治疗的新型分子生物标志物。
Biomark Res. 2022 May 31;10(1):38. doi: 10.1186/s40364-022-00385-1.